Status:
UNKNOWN
Amoxicillin to Prevent Bacteria and Inflammatory Biomarkers After Intensive Periodontal Therapy
Lead Sponsor:
Universidad El Bosque, Bogotá
Conditions:
Chronic Periodontitis
Bacteremia
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
Brief Summary
There are not published studies evaluating the incidence, nature, magnitude and/or duration of bacteremia after periodontal treatment. The pre-surgical antibiotics have been studied particullary over ...
Detailed Description
A randomized, triple-blind clinical trial with 90 participants will be conducted (age range18-65 years) with chronic periodontitis will be received and intensive periodontal therapy under local anaest...
Eligibility Criteria
Inclusion
- Subjects with chronic periodontitis (Ameriacam Academy of Periodontology 2015), having at least 2 teeth for quadrant with periodontal probing pockets depth ≥ 5 mm.
Exclusion
- Pregnant and lactating women, Diabetes, hypertension, Obesity, Allergy to penicillin, consumption of systemic antimicrobial or anti-inflamatory drugs in the last 2 months, Autoimmune diseases, patients with medical conditions that required antibiotic premedication such as prosthetic heart valve replacement, skeletal joint replacement, previous history of infective endocarditis and history of rheumatic fever.
Key Trial Info
Start Date :
September 21 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 31 2018
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT03354338
Start Date
September 21 2017
End Date
July 31 2018
Last Update
November 27 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Luis Antonio Noriega Frontado
Bogotá, Bogota D.C., Colombia, 1101